Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents

Oncogene volume 22, pages 6629–6638 (2003)Cite this article

Abstract

Conventional treatment of non-small-cell lung cancer (NSCLC) has apparently reached a plateau of effectiveness in improving the survival of NSCLC patients. Although neoadjuvant and adjuvant therapies in early stages are under investigation and some progress has been achieved in the management of locally advanced and advanced disease, treatment outcomes for NSCLC are still to be considered dismal. The majority of patients affected from NSCLC experience metastatic disease and optimization of chemotherapy is unlikely to produce further substantial survival improvement, with symptom relief and quality of life still being the primary goal of treatment. Based on this background, clinical investigation of novel treatment strategies is mandatory. As our understanding of tumor cell biology has increased and several molecular targets for NSCLC have been identified, a number of new biologic agents have been developed. Targeted therapy describes treatment strategies that focus on cell signaling and other biologic pathways involved in tumorigenesis. Several targeted agents have been introduced in clinical trials in NSCLC, the majority in advanced disease, and some phase III studies have already produced definitive results. Currently, the minority of these new agents offer promise of improved outcomes and negative results are more common to be reported than positive ones. However, important lessons can be learned from this first generation of clinical trials that should be considered the first step of clinical research in this field.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Adjei AA . (2001). J. Natl. Cancer Inst., 93, 1062–1074.

  • Altorki NK, Keresztes RS, Port JL, Flieder DB, Ferrara CA, Pasmantier MW, Libby DM, Yankelevitz D and Dannenberg AJ . (2002). Proc. Am. Soc. Clin. Oncol., 21, 26a.

  • Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A and Mulshine JL . (1996). J. Clin. Invest., 97, 806–813.

  • Basser R, Hurwitz H, Barge A, Davis I, DeBoer R, Holden S, McArthur G, McKinley M, Nairn K, Persky M, Rischin D, Rosenthal M, Swaisland H and Eckhardt G . (2001). Proc. Am. Soc. Clin. Oncol., 20, 100a.

  • Berardo MD, Elledge RM, Moor C, Clark GM, Osborne CK and Allred DC . (1998). Cancer, 82, 1296–1302.

  • Betensky RA, Louis DN and Cairncross JG . (2002). J. Clin. Oncol., 20, 2495–2499.

  • Bunn PA, Helfrich B, Soriano AF, Franklin WA, Varella-Garcia M, Hirsch FR, Baron A, Zeng C and Chan DC . (2001). Clin. Cancer Res., 7, 3239–3250.

  • Burkes RL, Ginsberg RJ, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG and Cooper JD . (1992). J. Clin. Oncol., 10, 580–586.

  • Carbone D, Choy H, Csiki I, Thao D, Campbell N, Garcia B, Morrow J, Saha D, Johnson DH and Sandler A . (2002). Proc. Am. Soc. Clin. Oncol., 21, 1270.

  • Ciardiello F, Bianco R, Damiano V, De Lorenzo S, Pepe S, De Placido S, Fan Z, Mendelsohn J, Bianco AR and Tortora G . (1999). Clin. Cancer Res., 5, 909–916.

  • Ciardiello F and Tortora G . (2001). Clin. Cancer Res., 7, 2958–2970.

  • Cox G, Vyberg M, Melgaard B, Askaa J, Oster A and O'Byrne KJ . (2001). Int. J. Cancer, 92, 480–483.

  • Curran WJ, Scott C, Langer C, Komaki J, Lee J, Hauser S, Movsas B, Wasserman TH, Rosenthal S, Byhardt R, Sause W and Cox J . (2000). Proc. Am. Soc. Clin. Oncol., 19, 484a.

  • Dang T, Johnson DH, Kelly K, Rizvi N, Holmlund J and Dorr A . (2001). Proc. Am. Soc. Clin. Oncol., 20, 332a.

  • Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C and French Thoracic Cooperative Group. (2002). J. Clin. Oncol., 20, 247–253.

  • Du Bois RN and Smalley WE . (1996). J. Gastroenterol., 31, 898–906.

  • Elderly Lung Cancer Vinorelbine Italian Study Group. (1999). J. Natl. Cancer Inst., 91, 66–72.

  • Falcey J, Pfister D, Cohen R, Cooper M, Bowden C, Burtness B, Mendelsohn J and Waksal H . (1997). Proc. Am. Soc. Clin. Oncol., 16, 383a.

  • Fosslien E . (2000). Ann. Clin. Lab. Sci., 30, 3–21.

  • Franqois B, Champagne P, Evans W, Jean L, Gerald B, Falardeau P, Hariton C and Dupont E . (2001). Proc. Am. Soc. Clin. Oncol., 20, 277b.

  • Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP and Baselga J . (2003). J. Clin. Oncol., 21, 2237–2246.

  • Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N and Ariyoshi Y . (1999). J. Clin. Oncol., 17, 2692–2699.

  • Gadgeel SM, Thatai L, Kraut M, Wozniak A, Worden F, Ward D, Belzer K, Hodges C and Kalemkerian GP . (2003). Proc. Am. Soc. Clin. Oncol., 22, 684.

  • Gatzemeier U, Groth G, Hirsch V, Butts CA, Van Zandwijk N, Shepherd F, Langer B and Rosso R . (2002). Proc. Am. Soc. Clin. Oncol., 21, 297a.

  • Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Palamidas P, Vlachonikolis I and Greek Oncology Cooperative Group (GOCG) for Lung Cancer. (2001). Lancet, 357, 1478–1484.

  • Giaccone G, Johnson DH, Manegold C, Scagliotti GV, Rosell R, Wolf M, Rennie P, Ochs J, Averbuch S and Fandi A . (2002). Ann. Oncol., 13, 2.

  • Gridelli C, Maione P, Colantuoni C and Rossi A . (2002a). Curr. Med. Chem., 9, 1487–1495.

  • Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi FV, Barbera S, Ferraù F, Piazza E, Rosetti F, Clerici M, Bertetto O, Robbiati SF, Frontini L, Sacco C, Castiglione F, Favaretto A, Novello S, Migliorino MR, Gasparini G, Galetta D, laffaioli RV and Gebbia V . (2003). J. Natl. Cancer Inst., 95, 362–372.

  • Gridelli C, Shepherd F, Perrone F, Illiano A, Piantedosi FV, Robbiati SF, Manzione L, Barbera S, Frontini L, Veltri E, Cigolari S, Findlay BP, Hirsh V, Seymour L, Bezjak A and Gallo C . (2002b). Proc. Am. Soc. Clin. Oncol., 21, 1165.

  • Gupta E, Huang M, Mao Y, Patel R, Tarby C, Daniels R, Kollia G, Naglich J, Humphrey J, Hurwitz H, Rizvi N and Sonnichsen D . (2001). Proc. Am. Soc. Clin. Oncol., 20, 76a.

  • Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI and Rigas B . (1996). Biochem. Pharmacol., 52, 237–245.

  • Herbst RS, Maddox AM, Rothenberg ML, Small EJ, Rubin EH, Baselga J, Rojo F, Hong WK, Swaisland H, Averbuch SD, Ochs J and LoRusso PM . (2002). J. Clin. Oncol., 20, 3815–3825.

  • Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura, Ogawa M and Takahashi T . (2000). Clin Cancer Res, 6, 2006–2011.

  • Hida T, Leyton J, Makheja AN, Ben-av P, Hla T, Martinez A, Mulshine J, Malkani S, Chung P and Moody TW . (1998a). Anticancer Res., 18, 775–782.

  • Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T and Takahashi T . (1998b). Cancer Res., 58, 3761–3764.

  • Johnson DH, Csiki I, Gonzalez A, Carbone DP, Gautam S, Campbell N, Morrow J and Sandler A . (2003). Proc. Am. Soc. Clin. Oncol., 22, 640.

  • Johnson DH, DeVore R, Kabbinavar F, Herbst R, Holmgren E and Novotny W . (2001). Proc. Am. Soc. Clin. Oncol., 20, 315a.

  • Johnson DH, Herbst R, Giaccone G, Schiller J, Natale RB, Miller V, Wolf M, Helton A, Averbuch S and Grous J . (2002). Ann. Oncol., 13, 127.

  • Kato H, Tsuboi M, Ohta M, Hata E, Tsubota N, Hamajima N, Wada H, Suemasu K, Otha M and for the Lung Cancer Research Group. (2003). Proc. Am. Soc. Clin. Oncol., 22, 621.

  • Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB and Johnson DH . (2000). N. Engl. J. Med., 343, 1217–1222.

  • Kelley DJ, Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Ramonetti JT and Dannenberg AJ . (1997). Carcinogenesis, 18, 795–799.

  • Kelly K, Crowley J, Bunn Jr PA, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB and Gandara DR . (2001). J. Clin. Oncol., 19, 3210–3218.

  • Kelly K, Hanna N, Rosemberg A, Bunn PA and Needle MN . (2003). Proc. Am. Soc. Clin. Oncol., 22, 644.

  • Keshet E and Ben-Sasson SA . (1999). J. Clin. Invest., 104, 1497–1501.

  • Khuri FR, Glisson BS, Meyers ML, Herbst RS, Thall PF, Munden RF, Bangert S, Cascino M, Blumenschein G, Pisters K and Hong WK . (2000). Proc. Am. Soc. Clin. Oncol., 19, 205a.

  • Kim ES, Mauer AM, Tran HAT, Liu D, Gladish G, Dicke K, Needle MN, Vokes EE, Hong WK and Herbst RS . (2003). Proc. Am. Soc. Clin. Oncol., 22, 642.

  • Korn EL, Arbuck SG, Pluda JM, Simon R, Kaplan RS and Christian MC . (2001). J. Clin. Oncol., 19, 265–272.

  • Kris MG, Natale BR, Herbst RS, Lynch TJ, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis C, Albain KS, Brahmer JR, Sandler A, Crawford J, Lutzker SG, Lilenbaum R, Helms L, Wolf M, Averbuch S, Ochs J and Kay A . (2002). Proc. Am. Soc. Clin. Oncol., 21, 292a.

  • Krug LM, Miller VA, Crapanzano J, Ng KK, Pizzo B, Tyson L, McClean N, Azzoli CG, Heelan RT, Ginsberg M, Venkatraman E and Kris MG . (2001). Proc. Am. Soc. Clin. Oncol., 20, 333a.

  • Kuenen BC, Rosen L, Smit EF, Parson MR, Levi M, Ruijter R, Huisman H, Kedde MA, Noordhuis P, van der Vijgh WJ, Peters GJ, Cropp GF, Scigalla P, Hoekman K, Pinedo HM and Giaccone G . (2002). J. Clin. Oncol., 20, 1657–1667.

  • Langer CJ, Adak S, Thor A, Vangel M and Johnson D . (2001). Proc. Am. Soc. Clin. Oncol., 20, 315a.

  • Le Chevalier T and for the IALT Investigators. (2003). Proc. Am. Soc. Clin. Oncol., 22, 2.

  • Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C and Shepard HM . (1993). Cancer Immunol. Immunother., 37, 255–263.

  • Lynch TJ, Raju R, Lind M, Riviere A, Gatzmeier U, Drorr A, Holmlund J, Yuen A and Sikic B . (2003). Proc. Am. Soc. Clin. Oncol., 22, 623.

  • Meta-analysis Trialist Group.(1998). Lancet, 352, 257–263.

  • Mininberg ED, Herbst RS, Henderson T, Kim E, Hong WK, Mass R, Novotny W, Garcia B, Johnson D and Sandler A . (2003). Proc. Am. Soc. Clin. Oncol., 22, 627.

  • Nemunaitis J, Holmlund JT, Kraynak M, Richards D, Bruce J, Ognoskie N, Kwoh TJ, Geary R, Dorr A, Von Hoff D and Eckhardt SG . (1999). J. Clin. Oncol., 17, 3586–3595.

  • Nishizuka Y . (1988). Nature, 334, 661–665.

  • Non Small Cell Lung Cancer Collaborative Group. (1995). BMJ, 311, 899–909.

  • Normanno N, Campiglio M, De LA, Somenzi G, Maiello M, Ciardiello F, Gianni L, Salomon DS and Menard S . (2002). Ann. Oncol., 13, 65–72.

  • Parkin DM . (2001). Lancet Oncol., 2, 533–543.

  • Perez-Soler R, Chachoua A, Huberman M, Karp D, Rigas J, Hammond L, Rowinsky E, Preston G, Ferrante KJ, Allen LF, Nadler PI and Bonomi P . (2001). Proc. Am. Soc. Clin. Oncol., 20, 310a.

  • Piccart-Gebhart MJ, Branle F, de Valeriola D, Dubuisson M, Hennebert P, Gil T, Forget F, Seifert W, Thibault A, Bol C and Awada A . (2001). Proc. Am. Soc. Clin. Oncol., 20, 80a.

  • Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK and Du Bois RN . (2001). Clin. Cancer Res., 7, 2998–3005.

  • Ramaswamy S and Golub TR . (2002). J. Clin. Oncol., 20, 1932–1941.

  • Reed JC . (1999). Curr. Opin. Oncol., 11, 68–75.

  • Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S and Hanada M . (1996). J. Cell Biochem., 60, 23–32.

  • Rioux N and Castonguay A . (1998). Carcinogenesis, 19, 1393–1400.

  • Robert F, Blumenschein G, Dicke K, Tseng J, Saleh MN and Needle M . (2003). Proc. Am. Soc. Clin. Oncol., 22, 643.

  • Rosell R, Gomez-Codina J, Camps C, Javier Sanchez J, Maestre J, Padilla J, Canto A, Abad A and Roig J . (1999). Lung Cancer, 26, 7–14.

  • Rowinsky EK, Windle JJ and Von Hoff D . (1999). J. Clin. Oncol., 17, 3631–3652.

  • Salomon DS, Brandt R, Ciardiello F and Normanno N . (1995). Crit. Rev. Oncol. Haematol., 19, 183–232.

  • Sanchez-Alcazar JA, Bradbury DA, Pang L and Knox AJ . (2003). Lung Cancer, 40, 33–44.

  • Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH and Eastern Cooperative Oncology Group. (2002). N. Engl. J. Med., 346, 92–98.

  • Shin DM, Nemunaitis J, Zinner RG, Donato NJ, Snih HC, Myers JN, Zhang PS, Zentgraf RE, Khuri FR, Glisson BS, Eiseman I, Olson S, Bycott P, Lenehan PF and Hong WK . (2001). Proc. Am. Soc. Clin. Oncol., 20, 82a.

  • Smylie M, Mercier R, Aboulafia D, Tucker R, Bonomi P, Collier M, Keller M, Stuart-Smith J, Knowles M, Clendeninn NJ and Shepherd F . (2001). Proc. Am. Soc. Clin. Oncol., 20, 307a.

  • Soslow RA, Dannenberg JA, Rush D, Woerner BM, Khan KN, Masferrer J and Koki AT . (2000). Cancer, 89, 2637–2645.

  • Tamaoki T and Nakano H . (1990). Biotechnology, 8, 732–735.

  • Tonato M and on behalf of The ALPI/EORTC-LCG Investigators. (2002). Proc. Am. Soc. Clin. Oncol., 21, 290a.

  • Tortora G, Caputo R, Damiano V, Troiani T, Veneziani BM, De Placido S, Bianco AR, Zangemeister-Wittke U and Ciardiello F . (2003a). Clin. Cancer Res., 9, 866–871.

  • Tortora G, Caputo R, Damiano V, Melisi D, Bianco R, Fontanini G, Veneziani BM, De Placido S, Bianco AR and Ciardiello F . (2003b). Clin. Cancer Res., 9, 1566–1572.

  • Van Meerbeeck JP, Smit EF, Lianes P, Schramel F, Lenz M, Debruyne C, Giaccone G and EORTC-Lung cancer Group, Brussels, Belgium. (2001). Proc. Am. Soc. Clin. Oncol., 20, 308a.

  • Wakeling AE, Guy SP, Woodburn JR, Ashton SE, Curry BJ, Barker AJ and Gibson KH . (2002). Cancer Res., 62, 5749–5754.

  • Wedge SR, Ogilvie DJ and Dukes M . (2000). Proc. Am. Assoc. Cancer Res., 41, 3610.

  • Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, Boffey SJ, Valentine PJ, Curwen JO, Musgrove HL, Graham GA, Hughes GD, Thomas AP, Stokes ES, Curry B, Richmond GH, Wadsworth PF, Bigley AL and Hennequin LF . (2002). Cancer Res., 62, 4645–4655.

  • Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H and Ristimaki A . (1998). Cancer Res., 58, 4997–5001.

  • Yang XD, Jia XC, Corvalan JR, Wang P and Davis CG . (2001). Crit. Rev. Oncol. Hematol., 38, 17–23.

  • Yuen A, Halsey J, Fisher G, Advani R, Moore M, Saleh M, Ritch P, Harker G, Ahmed F, Jones C, Polikoff J, Keiser W, Kwoh T, Holmlund J, Dorr A and Sikic B . (2001). Proc. Am. Soc. Clin. Oncol., 20, 309a.

  • Zangemeister-Wittke U, Schenker T, Luedke GH and Stahel RA . (1998). Br. J. Cancer, 78, 1035–1042.

  • Zinner GR, Glisson BS, Pisters KM, Khuri FR, Oh YW, Ro JY, Ordonez NG, El-Naggar AK, Tran HT, Terry KA, Hong WK and Herbst RS . (2001). Proc. Am. Soc. Clin. Oncol., 20, 328a.

Download references

Author information

Authors and Affiliations

  1. Division of Medical Oncology, ‘S.G. Moscati’ Hospital, Via Circumvallazione, Avellino, 83100, Italy

    Cesare Gridelli, Antonio Rossi & Paolo Maione

Authors
  1. Cesare Gridelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo Maione
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cesare Gridelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gridelli, C., Rossi, A. & Maione, P. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents. Oncogene 22, 6629–6638 (2003). https://doi.org/10.1038/sj.onc.1206957

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206957

Keywords

This article is cited by

Search

Advanced search

Quick links